Literature DB >> 23340032

Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy.

Elizabeth Reineck1, Brice Rolston, Jennifer L Bragg-Gresham, Lisa Salberg, Linda Baty, Suwen Kumar, Matthew T Wheeler, Euan Ashley, Sara Saberi, Sharlene M Day.   

Abstract

The clinical expression of hypertrophic cardiomyopathy (HC) is undoubtedly influenced by modifying genetic and environmental factors. Lifestyle practices such as tobacco and alcohol use, poor nutritional intake, and physical inactivity are strongly associated with adverse cardiovascular outcomes and increased mortality in the general population. Before addressing the direct effect of such modifiable factors on the natural history of HC, it is critical to define their prevalence in this population. A voluntary survey, drawing questions in part from the 2007 to 2008 National Health and Nutrition Examination Survey (NHANES), was posted on the HC Association website and administered to patients with HC at the University of Michigan. Propensity score matching to NHANES participants was used. Dichotomous and continuous health behaviors were analyzed using logistic and linear regression, respectively, and adjusted for body mass index and propensity score quintile. Compared to the matched NHANES participants, the patients with HC reported significantly less alcohol and tobacco use but also less time engaged in physical activity at work and for leisure. Time spent participating in vigorous or moderate activity was a strong predictor of self-reported exercise capacity. The body mass index was greater in the HC cohort than in the NHANES cohort. Exercise restrictions negatively affected emotional well-being in most surveyed subjects. In conclusion, patients with HC are less active than the general United States population. The well-established relation of inactivity, obesity, and cardiovascular mortality might be exaggerated in patients with HC. More data are needed on exercise in those with HC to strike a balance between acute risks and the long-term health benefits of exercise.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23340032     DOI: 10.1016/j.amjcard.2012.12.018

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

Review 1.  Return-to-Play in 2017 and the Role of Shared Decision-Making in Patients with Inherited and Acquired Channelopathies and Cardiomyopathies.

Authors:  Kia Afshar; T Jared Bunch
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-14

2.  Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy.

Authors:  Ankit B Shah; Mary Z Bechis; Marcel Brown; Jennifer Michaud Finch; Garrett Loomer; Erich Groezinger; Rory B Weiner; Meagan M Wasfy; Michael H Picard; Michael A Fifer; Gregory B Lewis; Aaron L Baggish
Journal:  J Physiol       Date:  2019-01-09       Impact factor: 5.182

Review 3.  Targeted Medical Therapies for Hypertrophic Cardiomyopathy.

Authors:  Carlo Fumagalli; Maria Grazia De Gregorio; Mattia Zampieri; Elisa Fedele; Alessia Tomberli; Chiara Chiriatti; Alberto Marchi; Iacopo Olivotto
Journal:  Curr Cardiol Rep       Date:  2020-01-28       Impact factor: 2.931

4.  Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.

Authors:  Sara Saberi; Matthew Wheeler; Jennifer Bragg-Gresham; Whitney Hornsby; Prachi P Agarwal; Anil Attili; Maryann Concannon; Annika M Dries; Yael Shmargad; Heidi Salisbury; Suwen Kumar; Jonathan J Herrera; Jonathan Myers; Adam S Helms; Euan A Ashley; Sharlene M Day
Journal:  JAMA       Date:  2017-04-04       Impact factor: 56.272

5.  Exercise Recommendations in Pediatric HCM: Variation and Influence of Provider Characteristics.

Authors:  Robert D Whitehill; Seshadri Balaji; Michael Kelleman; Stephanie F Chandler; Dominic J Abrams; Chad Mao; Peter Fischbach; Robert Campbell
Journal:  Pediatr Cardiol       Date:  2021-08-18       Impact factor: 1.655

6.  Hypertrophic cardiomyopathy and exercise restrictions: time to let the shackles off?

Authors:  Yuen W Liao; James Redfern; John D Somauroo; Robert M Cooper
Journal:  Br J Cardiol       Date:  2020-05-20

7.  Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.

Authors:  Carlo Fumagalli; Niccolò Maurizi; Sharlene M Day; Euan A Ashley; Michelle Michels; Steven D Colan; Daniel Jacoby; Niccolò Marchionni; Justin Vincent-Tompkins; Carolyn Y Ho; Iacopo Olivotto
Journal:  JAMA Cardiol       Date:  2020-01-01       Impact factor: 14.676

8.  Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMR.

Authors:  Christopher M Kramer; John P DiMarco; Paul Kolm; Carolyn Y Ho; Milind Y Desai; Raymond Y Kwong; Sarahfaye F Dolman; Patrice Desvigne-Nickens; Nancy Geller; Dong-Yun Kim; Martin S Maron; Evan Appelbaum; Michael Jerosch-Herold; Matthias G Friedrich; Jeanette Schulz-Menger; Stefan K Piechnik; Masliza Mahmod; Daniel Jacoby; James White; Amedeo Chiribiri; Adam Helms; Lubna Choudhury; Michelle Michels; William Bradlow; Michael Salerno; Dana K Dawson; Jonathan W Weinsaft; Colin Berry; Sherif F Nagueh; Chiara Buccarelli-Ducci; Anjali Owens; Barbara Casadei; Hugh Watkins; William S Weintraub; Stefan Neubauer
Journal:  JACC Clin Electrophysiol       Date:  2021-06-30

Review 9.  Hypertrophic Cardiomyopathy: Updates Through the Lens of Sports Cardiology.

Authors:  Bradley S Lander; Dermot M Phelan; Matthew W Martinez; Elizabeth H Dineen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-05-25

Review 10.  Psychological Issues in Managing Families with Inherited Cardiovascular Diseases.

Authors:  Jodie Ingles
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 5.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.